Literature DB >> 12072003

Urticarial intolerance reaction to cetirizine.

S Schröter1, B Damveld, W C Marsch.   

Abstract

The paradoxical acute exacerbation of pre-existing chronic idiopathic urticaria accompanied by intense generalized pruritus, facial oedema, and dyspnoea in a 36-year-old-woman 3-4 h after a single oral dose of 10 mg cetirizine (Zyrtec tablets), suggested the presence of an underlying intolerance reaction. However, a type I hypersensitivity reaction also had to be excluded. Detailed allergy testing supported the view that the patient had suffered an intolerance reaction to cetirizine. This is the third known case of most probably a nonallergic generalized urticaria following the administration of cetirizine, a drug with extensive usage worldwide. However a type I sensitization to cetirizine is indeed possible, as has been demonstrated in this research with the verification of cetirizine-specific IgE antibodies in one of the control sera.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12072003     DOI: 10.1046/j.1365-2230.2002.00988.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  5 in total

1.  Cetirizine-induced anaphylaxis: a rare adverse drug reaction.

Authors:  Nisha Afonso; Pankaj Shetgaonkar; Amit Dang; Padmanabh V Rataboli
Journal:  Br J Clin Pharmacol       Date:  2009-02-23       Impact factor: 4.335

Review 2.  Second-generation antihistamines: actions and efficacy in the management of allergic disorders.

Authors:  Larry K Golightly; Leon S Greos
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Cetirizine: a review of its use in allergic disorders.

Authors:  Monique P Curran; Lesley J Scott; Caroline M Perry
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Fexofenadine-induced urticaria.

Authors:  Sang Woo Lee; Ji Yeon Byun; You Won Choi; Ki Bum Myung; Hae Young Choi
Journal:  Ann Dermatol       Date:  2011-12-27       Impact factor: 1.444

5.  A case of levocetirizine-induced fixed drug eruption and cross-reaction with piperazine derivatives.

Authors:  Mi-Yeong Kim; Eun-Jung Jo; Yoon-Seok Chang; Sang-Heon Cho; Kyung-Up Min; Sae-Hoon Kim
Journal:  Asia Pac Allergy       Date:  2013-10-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.